Dystrophin mutations may have clinically detectable effects on female carriers. The most common feature is a proximal myopathy, which may be severe. Mild abnormalities are seen on muscle biopsy, EMG or CK measurement in over 80% of carriers.
Females may be severely affected because:
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page